Shin‐Yun Liu

413 citations
11 papers · 345 indexed · h-index 7
Topics
Cardiac Ischemia and Reperfusion (3 papers)Glycosylation and Glycoproteins Research (2 papers)Nanoparticle-Based Drug Delivery (2 papers)

In The Last Decade

Shin‐Yun Liu

10 papers receiving 339 citations

Peers

Shin‐Yun Liu
Comparison fields: 5 of 83
  • Molecular Biology 149
  • Biomedical Engineering 82
  • Surgery 62
  • Immunology 59
  • Biomaterials 54
Replace Yumiko Nakashima with:
Yumiko Nakashima Japan
Rongfu Liu China
Kelly Koral United States
Bingqiang Gao China
Michelle Kuzma Canada
Lingxiao Zhang China
Chenqi Zhu China
Hualin Ma China
Weilin Sang China
Shin‐Yun Liu relative to Yumiko Nakashima Japan Yumiko Nakashima's profile →
Citations per field
00.5×5.9×
Yumiko Nakashima · 1×
Citations per year

Countries citing papers authored by Shin‐Yun Liu

Since Specialization
Citations

This map shows the geographic impact of Shin‐Yun Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shin‐Yun Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shin‐Yun Liu more than expected).

Fields of papers citing papers by Shin‐Yun Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shin‐Yun Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shin‐Yun Liu. The network helps show where Shin‐Yun Liu may publish in the future.

Co-authorship network of co-authors of Shin‐Yun Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Shin‐Yun Liu. A scholar is included among the top collaborators of Shin‐Yun Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shin‐Yun Liu. Shin‐Yun Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 0
2 2
3 16
4 6
5 43
6
The O-glycosylating enzyme GALNT2 suppresses the malignancy of gastric adenocarcinoma by reducing EGFR activities.
24
7 10
8 41
9 5
10 96
11 102

About Shin‐Yun Liu

Shin‐Yun Liu is a scholar working on Developmental Neuroscience, Sensory Systems and Immunology, having authored 11 papers that have together received 345 indexed citations. Recurring topics across this work include Cardiac Ischemia and Reperfusion (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Nanoparticle-Based Drug Delivery (2 papers). The work is most often cited by research in Biomaterials (54 citations), Nephrology (27 citations) and Clinical Biochemistry (23 citations). Shin‐Yun Liu has collaborated with scholars based in Taiwan, United States and Australia. Frequent co-authors include I‐Rue Lai, Hong‐Shiee Lai, Haowei Tang, Chia-Hung Liu, Kevin C.‐W. Wu, Shih‐Hsiang Liao, Min‐Chuan Huang, Kuan‐Yu Hung, Chia‐Lang Hsu and Chia‐Tung Shun. Their work appears in journals such as Circulation Research, ACS Applied Materials & Interfaces and Antioxidants and Redox Signaling.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026